Novartis 2Q 2Q Revenues: $14.9 billion (+27%) 2Q Earnings: $2.7 billion (+12%) YTD Revenues: $28.9 billion (+21%) YTD Earnings: $5.5 billion (+3%) Comments: Revenues were up 19% in constant currencies (c.c.) for 2Q11 and +16% YTD. Pharma revenues were up 10% (+2% c.c.) to $8.3 billion in 2Q, with recently launched products contributing $2.3 billion (+34% c.c.). Alcon revenues were up 12% (6% c.c.) to $2.6 billion. Sandoz (generic) revenue rose 25% (16% c.c.) to $2.5 billion. For the YTD, ph...